Navigation Links
Researchers report first success of targeted therapy in most common non-small cell lung cancer
Date:11/28/2012

BOSTON - A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Published online today in The Lancet Oncology, the combination of chemotherapy and the targeted drug selumetinib was more effective than chemotherapy alone in a clinical trial involving patients with a form of non-small cell lung cancer (NSCLC) that carries a mutation in the gene KRAS a variety that represents about 20 percent of all NSCLC cases. Previously, no targeted agent, either alone or in combination with another drug, had proven beneficial in a trial involving patients with this type of NSCLC.

The 87 patients who participated in the new, phase II trial conducted at 67 sites around the world had advanced, KRAS-mutant NSCLC that had failed initial chemotherapy. The participants were randomly assigned to receive either selumetinib and the chemotherapy agent docetaxel or docetaxel alone.

Investigators found that while 37 percent of the patients in the selumetinib group experienced some shrinkage of their tumor, none of the patients in the docetaxel-only group did. Of particular significance, patients receiving selumetinib lived a median of 5.3 months before their cancer began to worsen, compared to 2.1 months for those receiving chemotherapy alone. (Patients in the selumetinib group also survived longer, on average, than those in the docetaxel group 9.4 months compared to 5.2 months but the improvement was not considered statistically significant.)

"Our findings suggest that selumetinib and docetaxel work synergistically each enhancing the effect of the other," says the study's lead author, Pasi A. Janne, MD, PhD, of Dana-Farber. "This opens the possibility that there may finally be a therapeutic strategy
'/>"/>

Contact: Robbin Ray
Robbin_Ray@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. USC, Oxford researchers find high fructose corn syrup-global prevalence of diabetes link
2. Researchers study cry acoustics to determine risk for autism
3. Researchers explore social media as preventative method for infectious diseases
4. New mechanism for cancer progression discovered by UNC and Harvard researchers
5. Researchers identify physiological evidence of chemo brain
6. Researchers find chemical switches for neurodegenerative diseases
7. Release all Tamiflu data as promised, argue researchers
8. Researchers link new molecular culprit to breast cancer progression
9. Researchers discover gender-based differences in Alzheimers disease
10. Researchers find evidence that brain compensates after traumatic injury
11. Researchers find decline in availability and use of key treatment for depression
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers report first success of targeted therapy in most common non-small cell lung cancer
(Date:4/17/2015)... Texas (PRWEB) April 17, 2015 From the ... years ago, the Texas non-profit organization has empowered young people ... its effort to bring fresh water and the Gospel ... with Liberty University. Between March 17 and 27, students, faculty ... provide 7,000 Liberians with fresh water and the Good News ...
(Date:4/17/2015)... Representatives Jim Himes (D-CT) and Ed ... HR 1849 in congress on April 16, 2015 in ... patients with the genetic disease. , The bill, ... the first to create a federally led and financed ... hemorrhagic telangiectasia. This would effectively prevent premature death and ...
(Date:4/17/2015)... 2015 At the end of February ... the “Salute to the Oscars” in the Stardust Penthouse ... overlooking the impressive Los Angeles skyline. These events honoring ... Durkin, LA’s leading producer of sustainable product placement in ... world’s premier providers of eco-friendly and socially conscious products ...
(Date:4/17/2015)... April 17, 2015 Baptist Health and ... signed a partnership agreement designed to transform oncology care ... institutions have agreed to create a joint cancer program ... and translational research. Baptist MD Anderson Cancer Center is ... a single destination for highly coordinated, multidisciplinary cancer care ...
(Date:4/17/2015)... April 17, 2015 The American College of Traditional ... Free Application Day on April 29. The event will be held ... located at 555 DeHaro St. in San Francisco, CA. , The ... Check in at the DeHaro campus (room F), 11:10 a.m. ... campus, Noon – Light lunch with current students, faculty and staff, ...
Breaking Medicine News(10 mins):Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:American College of Traditional Chinese Medicine Hosts Open House 2
... have significantly cut down use of illicit drugs, but have ... ,Dr. Grant Mitchell, chief of psychiatry at Northern Westchester ... me. As we write more and more prescriptions for potentially ... don't have the same need to go out and procure ...
... that the people of India constitute more than ... been underrepresented in studies related //to genetic diseases. ... diseases associated with urban and western lifestyles have ... association studies of particular importance. ,In ...
... published online by Developmental Biology, members of Dr. John ... report the discovery// of a new protein within a ... male contraceptive drugs. ,“There’s considerable interest in ... Center for Research in Contraceptive and Reproductive Health. “To ...
... estimate of the repercussions of a potential flu pandemic showed ... the underprivileged nations, could pay// with their life. , ... infamous 1918 Spanish flu, which wiped out nearly 20 million ... of Public Health and the University of Queensland studied the ...
... with neuroblastoma tumors have been successfully treated with genetically ... activated a chemotherapy drug directly at// those sites, according ... their colleagues at City of Hope National Medical Center ... Canada). Neuroblastoma is a solid tumor that arises in ...
... mind set play a significant role in healing process, according ... ,During the experiment, pain was first induced in 40 ... to expect reduced pain after the application of a cream ... suggest : faith in a Doctor or a medicine leads ...
Cached Medicine News:Health News:Researchers Make Progress in Studying Genetic Traits of India-born Populations 2Health News:Male Contraception: Discovery Stirring Interest Among Scientists, Drug Developers 2Health News:Genetically Modified Cells Attack Tumors 2Health News:Genetically Modified Cells Attack Tumors 3Health News:Role Of Faith In Healing Process 2
(Date:4/17/2015)... , April 17, 2015  Trovagene, Inc., (NASDAQ: ... today that clinical data presented at the 2015 ... urine-based Precision Cancer Monitoring ℠ (PCM) platform ... of EGFR T790M mutations in metastatic ... of EGFR T790M Mutation in Urinary Circulating Tumor ...
(Date:4/17/2015)... 2015 Steven Rash , the CEO of ... operating subsidiary American Seed & Oil Company, presented the ... yesterday in New York City.  Mr. Rash,s presentation featured ... Seed & Oil Company has recently announced the ... Seed Foods , the EpiVape , and ...
(Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/256szd/corporate ) has ... Pharma in 2014 - a Perspective of Mental Health ... offering. For the first time, in 2014, ... of the pharmaceutical industry held by patient groups with ... patient organisations representing all therapy areas. - ...
Breaking Medicine Technology:Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3
... , , MINNEAPOLIS and ST. PAUL, Minn., Nov. 16 ... connected with friends, keeping up with school, and simply passing time ... More and more patients are relying on technology to help, from ... But when that technology fails, it can bring added stress to ...
... , WASHINGTON, Nov. 16 Despite ... market has increased approximately 15 percent in the past two ... Deloitte Center for Health Solutions. Retail clinic market growth, however, ... and will accelerate above 30 percent from 2013-2014, according to ...
Cached Medicine Technology:Children's Hospitals and Clinics of Minnesota Teams With Geek Squad to Open First Ever In-Hospital Precinct 2Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 2Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 3Health Care Retail Clinics Continue Gradual Expansion Through 2012: Deloitte Center for Health Solutions Report 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: